Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
Research has found a connection between weight loss drugs such as Ozempic and Zepbound and serious eye conditions, leading to concerns about "Ozempic blindness." The exact reason for this association ...
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
The Food and Drug Administration (FDA) has expanded the labeling for Izervay™ (avacincaptad pegol intravitreal solution) to include longer-term ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.
Hosted on MSN2d
LLY Rises More Than 4% in a Week: How to Play the StockEli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
Aja Beckett quit her job after her weight-loss shot-tracking app, Shotsy, took off on Reddit.
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback